Stock Market news at lse.co.uk - RSS News Feeds

Reckitt Benckiser Share News (RB.)



Share News for Reckitt Benckiser (RB.)


Share Price: 4,828.00Bid: 4,807.00Ask: 4,808.00Change: 0.00 (0.00%)No Movement on Reckitt Ben. Gp
Spread: 1.00Spread as %: 0.02%Open: 4,780.00High: 4,828.00Low: 4,737.00Yesterday’s Close: 4,828.00




BRIEF-ING cuts European food sector; ups HPC sector

Fri, 14th Nov 2008 06:45

Nov 14 (Reuters) -

* ING cuts European food sector to neutral from outperform

* ING
raises European household personal care and cosmetics (hpc) sector to

neutral from underperform

* ING cuts Cadbury PLC to sell from hold; price target to 500P from

560P

* ING cuts Nestle SA price target to 48.5 SFR from 49.5 SFR; keeps

hold rating

* ING cuts Beiersdorf AG price target to 42 EUR from 44 EUR; keeps

hold rating

* ING raises Henkel to buy from hold; cuts price target to 25.5 EUR

from 31 EUR

* ING cuts Reckitt Benckiser price target to 3000P from 3100P; keeps buy

rating

* ING says within European food sector, it continues to favour danone

before Unilever

* ING says in European hpc sector, it favours household names over cosmetics

players

* ING says rating upgrade on Henkel based on valuation



(Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)

COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.







MARKET PULSE-Merck, Titan Pharma, Neutral Tandem, Synacor, Brightcove

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49sfaq23t; for the Morning
[1 May '13]

UPDATE 2-FDA rejects Titan drug for opioid dependence

* FDA asks for more data on Probuphine* Titan shares fall 72 percent in early trading* Titan says extremely surprised and disappointed by rulingBy Ton
[1 May '13]

UPDATE 1-Severe U.S. flu season helps Reckitt top forecasts

* Q1 revenues 2.52 bln stg vs forecast 2.47 bln* Growth driven by U.S. flu season, Dettol and Lysol sales* Pharma business up 19 pct, ahead of forecas
[22 Apr '13]

Reckitt benefits from flu season to begin 2013 strongly

LONDON, April 22 (Reuters) - Reckitt Benckiser reported a strong start to 2013 as the maker of Strepsils lozenges and Mucinex decongestant continued
[22 Apr '13]

UPDATE 4-Germany's JAB to buy Douwe Egberts firm in $9.8 bln deal

* Joh A Benckiser agrees to buy D.E Master Blenders* 12.5 euros per share cash bid is below initial proposal* No plans to sell Reckitt shares to fund
[12 Apr '13]

Two U.S. nutrition companies looking for buyers -sources

By Martinne Geller and Olivia OranNEW YORK, April 5 (Reuters) - Santa Cruz Nutritionals and Nellson Nutraceutical LLC are looking for buyers as the la
[5 Apr '13]

STOCKS NEWS EUROPE-D.E Master Blenders surges on takeover talks

D.E Master Blenders surges more than 26 percent to lead FTSEurofirst 300 gainers in heavy volume on news of takeover talks with a German investor that
[28 Mar '13]

STOCKS NEWS EUROPE-Citi adds Reckitt to focus list, drops Danone

Reckitt Benckiser ascends to Citi's European focus list, replacing Danone, with the bank seeing the consumer health company receiving revenue upgrades
[21 Mar '13]



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.